9.73
-0.52 (-5.07%)
| Previous Close | 10.25 |
| Open | 10.24 |
| Volume | 959,501 |
| Avg. Volume (3M) | 2,220,832 |
| Market Cap | 622,916,928 |
| Price / Sales | 5.84 |
| Price / Book | 25.34 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2026 |
| Profit Margin | -100.62% |
| Operating Margin (TTM) | 13.62% |
| Diluted EPS (TTM) | -3.09 |
| Quarterly Revenue Growth (YOY) | 469.80% |
| Total Debt/Equity (MRQ) | 48.70% |
| Current Ratio (MRQ) | 2.93 |
| Operating Cash Flow (TTM) | -84.04 M |
| Levered Free Cash Flow (TTM) | -56.82 M |
| Return on Assets (TTM) | -17.56% |
| Return on Equity (TTM) | -47.44% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | REGENXBIO Inc. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -1.5 |
| Average | -0.83 |
|
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 7.70% |
| % Held by Institutions | 87.65% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |